TUESDAY NOV.8
15:00 -18:30 REGISTRATION & COCKTAIL
WEDNESDAY, NOV.9
8:30 Registration
9:30 Opening Remarks
Mr. Yutaka Shibata, President of Asahi Kasei Medical Co., Ltd., Japan
SESSION A: Viral Safety Studies of Biopharmaceuticals / Case Studies / Novel Technologies
CHAIRPERSON: Herbert Dichtelmüller Ph.D., Director of Virus Validation,
Biotest AG, Germany
9:45 - The Goal of Increasing Safety in Different Plasma Derivative Manufacturing Processes: 15 Years Experience of Grifols with Planova™ Nanofilt
Santiago Caballero, Ph.D., Biology, Head of Virus Validation Section (R&D),
Instituto Grifols, S.A., Spain
10:15 - Experience with Reduction of Small Non-enveloped Viruses
Johannes Blümel, Ph.D., Head of virus safety section,
Paul Ehrlich Institute, Germany
10:45 - COFFEE BREAK
11:15 -Consistent and Reliable 100% Retrovirus Removal by Planova™ 20N filter: Demonstration of Robust Log Reduction (>6.0) by Co-spiking Study
Dayue Chen, Ph.D., Virology Group Bioprocess Research and Development,
Eli Lilly and Company, USA
11:45 - Selection of a Virus Filter for a Plasma Product
Shirley Stagg, Ph.D., Senior Project Scientist, Biosafety and Product Development,
Bio Products Laboratory Ltd. (BPL), UK
12:15 - LUNCH
13:15 - Comparison of Downscale and Process Virus Retentive Filter
Marcel Asper, Ph.D., Study Director,
Charles River Biopharmaceutical Services GmbH, Germany
13:45 - Host Cell Protein (HCP) Removal by QyuSpeed™ D: Buffer Type Dependence and Two-Dimensional Electrophoresis (2DE) Profiling
Hironobu Shirataki, Ph.D., Manager, Technology Development Department,
Asahi Kasei Medical Co., Ltd., Bioprocess Division, Japan
14:15 - COFFEE BREAK
14:45 - Virus Removal by Adsorber Membrane QyuSpeed™ D
Eckhard Flechsig, Ph.D., Head of Virus Validation,
Biotest AG, Germany
15:15 - An Evaluation of the Removal of Porcine Circovirus by the Asahi Planova™15N, 20N, BioEX and QyuSpeed™ D (Membrane Absorber) Filtration Devices
Andy Bailey, Ph.D., CEO,
ViruSure GmbH, Austria
16:15 - Tour to COLOGNE TECHNICAL CENTER (CTC)
(120min) Demonstration of Automated Systems at the COLOGNE TECHNICAL CENTER, There will be two groups. One on Wednesday and the other on Thursday. Please register.
19:30 - COCKTAIL & DINNER
at the KÖLN SKY over the Top of the City
THURSDAY, NOV. 10
Session B: Process Validation / Optimization / Production
CHAIRPERSON: Michael Dieterle, Ph. D., Associate Director Downstream Development Process Science Biopharmaceuticals,
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
9:30 - Virus Inactivation at Low pH: Impact of Buffers, pH Value, Protein Concentration and Temperature on the Inactivation of Retroviruses
Michael Dieterle, Ph. D., Associate Director Downstream Development,
Boehringer Ingelheim GmbH&Co.KG, Germany
10:00 - Process Designing for Virus Removal Filter
Tomoko Hongo-Hirasaki, Ph.D., Manager, Technology Development Department,
Asahi Kasei Medical Co., Ltd., Bioprocess Division, Japan
10:30 - COFFEE BREAK
11:00 - Use of In-house Platform Data to Support Reduced Viral Clearance Validation
Stefan Hepbildikler, Ph.D., Director Recovery &Downstream Processing C,
Roche Pharma Biotech Development, Germany
11:30 - Implementation of Quality by Design to Nanofiltration of Plasma Products
Monique Ollivier, Ph.D., Head of Process Development,
Laboratoire Français du Fractionnement et des Biotechnologies (LFB), France
12:00 - Development & Comparability Data for QyuSpeed™ D Implementation in an Existing GMP Production Process of a Recombinant API
Iann Rancé, Ph.D., Director Process Development-Downstream & Analytics,
Cytheris S.A., France
12:30 - LUNCH
13:30 - FULL PLASTICS for a 1000L Disposable Production Line for Generic Antibody Manufacturing
Peter Rogge, Director DSP Production,
Rentschler Biotechnologie GmbH, Germany
14:00 - Implementation of Automatic Cleaning and Integrity Testing of Planova™ Filters at Sanquin Plasma Products
J.F. van de Laar, M.Sc., Plasma Products, Dept. of Process Support and Development,
Sanquin, The Netherlands
14:30 - New Concept of Integrity Test for Planova™ BioEX
Shinya Sekine, Manager, Technology Development Department,
Asahi Kasei Medical Co., Ltd., Bioprocess Division, Japan
15:00 - Closing Remarks
by Mr. Takashi Tsuboi, Managing Director Asahi Kasei Bioprocess Europe N.V./S.A
16:00 - Tour to COLOGNE TECHNICAL CENTER (CTC)
(120 min.) Demonstration of Automated Systems at the COLOGNE TECHNICAL CENTER, There will be two groups. This the second group date. Please register.
